中医药在以肺磨玻璃结节为特征的早期肺癌中应用进展
Progress in the Application of Traditional Chinese Medicine in Early Stage Lung Cancer Characterized by Pulmonary Ground Glass Nodules
DOI: 10.12677/TCM.2019.82021, PDF,    科研立项经费支持
作者: 肖晓宇, 焦丽静, 许 玲：上海中医药大学附属岳阳中西医结合医院，上海；李惠民：上海交通大学附属新华医院，上海
关键词: 肺磨玻璃结节；肺癌；预防；中医药；癌变；肺磨玻璃结节；肺癌；预防；中医药；癌变
摘要: 肺磨玻璃结节(Ground-Glass Nodule, GGN)，作为早期肺癌的非特异性影像学表现，具有恶性率高、遗传异质性突出、治疗对策难的特点。而GGN的长期随访检测，为中医药发挥治未病的特色提供了可能。本文梳理GGN的遗传学特征、研究现状，重点探讨了中医药在肺癌发生预防中的临床疗效及作用机制应用研究进展，以期为今后中医药在以GGN为特征的早期肺癌的临床防治及研究提供思路。
Abstract: Ground-glass nodule (GGN), as a non-specific imaging manifestation of early stage lung cancer, has the characteristics of high malignancy, prominent genetic heterogeneity, and difficult treatment strategies. For the long-term follow-up test of GGN, it is possible to play the role of “prevention of disease” for the treatment of traditional Chinese medicine. This paper reviews the genetic characteristics and research status of GGN, and focuses on the application of traditional Chinese medicine in the prevention and treatment of lung cancer. The aim is to provide ideas for early-stage lung cancer characterized by GGN.
文章引用：肖晓宇, 焦丽静, 李惠民, 许玲. 中医药在以肺磨玻璃结节为特征的早期肺癌中应用进展[J]. 中医学, 2019, 8(2): 111-119. https://doi.org/10.12677/TCM.2019.82021

参考文献

[1] Chen, W.Q., Zheng, R.S., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
[2] Duann, C.W., Hung, J.J., Hsu, P.K., et al. (2013) Surgical Outcomes in Lung Cancer Presenting as Ground-Glass Opacities of 3 cm or Less: A Review of 5 Years Experience. Journal of the Chinese Medical Association, 76, 693-697. [Google Scholar] [CrossRef] [PubMed]
[3] Pedersen, J.H., Saghir, Z., Wille, M.M., et al. (2016) Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer Screening: Radiology, Pathology, and Clinical Management. Lung Cancer, 30, 266-274.
[4] Scholten, E.T., Jacobs, C., van Ginneken, B., et al. (2013) Computer-Aided Segmentation and Volumetry of Artificial Ground-Glass Nodules at Chest CT. American Journal of Roentgenology, 201, 295-300. [Google Scholar] [CrossRef] 
[5] Hiramatsu, M., Inagaki, T., Inagaki, T., et al. (2008) Pulmonary Ground-Glass Opacity (GGO) Lesion-Large Size and a History of Lung Cancer Are Risk Factors for Growth. Journal of Thoracic Oncology, 3, 1245-1250. [Google Scholar] [CrossRef] 
[6] Cheng, Z.H., Shan, F., Yang, Y.S., et al. (2017) CT Characteristics of Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Systematic Review and Meta-Analysis. BioMed Central Medical Imaging, 17, 1-10.
[7] Wang, T.T., Zhang, T., Han, X.X., et al. (2015) Impact of the International Association for the Study of Cancer/American Thoracic Society/European Respiratory Society Classification of Stage I A Adenocarcinoma of the Lung: Correlation between Computed Tomography Images and EGFR and KRAS Gene Mutations. Experimental and Therapeutic Medicine, 9, 2095-2103. [Google Scholar] [CrossRef] [PubMed]
[8] Chung, J.-H., Che, G., Jheon, S., et al. (2009) Epidermal Growth Factor Receptor Mutation and Pathologic-Radiologic Correlation between Multiple Lung Nodules with Ground-Glass Opacity Differentiates Multicentric Origin from Imtrapulmonary Spread. Journal of Thoracic Oncology, 4, 1490-1495. [Google Scholar] [CrossRef] 
[9] Liu, M., He, W.-X., Song, N., et al. (2016) Discrepancy of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma Presenting as Multiple Ground-Glass Opacities. European Journal of Cardio-Thoracic Surgery, 50, 909-913. [Google Scholar] [CrossRef] [PubMed]
[10] MacMahon, H., Naidich, D.P., Goo, J.M., et al. (2017) Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleiscchner Society 2017. Radiology, 284, 228-243. [Google Scholar] [CrossRef] [PubMed]
[11] Chang, B., Hwang, J.H., Choi, Y.H., et al. (2013) Natural History of Pure Ground-Glass Opacity Lung Nodules Detected by Low Dose CT Scan. Chest, 143, 172-178. [Google Scholar] [CrossRef] [PubMed]
[12] 付金花, 陈武飞, 滑炎卿. 倍增时间在磨玻璃结节随访中的应用价值[J]. 临床放射学杂志,2017, 36(6): 886-888.
[13] Kakinuma, R., Noguchi, M., Ashizawa, K., et al. (2016) Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study. Journal of Thoracic Oncology, 11, 1012-1028. [Google Scholar] [CrossRef] [PubMed]
[14] 朱克俭, 张亚利, 欧阳剑虹, 等. 保肺饮预防肺癌的临床流行病学研究[J]. 中国中医药科技, 1997, 4(6): 332-333.
[15] 孙兆泉, 朱克俭, 刘礼意. 保肺饮对诱生肺癌大鼠的影响[J]. 中国中西医结合外科杂志, 1998, 4(4): 198-200.
[16] 谭小宁, 刘天舒, 王红梅. 保肺饮对肺癌细胞EMT的作用及机制研究[J]. 湖南中医杂志, 2016, 32(11): 159-160.
[17] 郭慧君, 朱金华, 柳招红, 等. 六味地黄丸在肺癌发生早期对TNF-α和PCNA的影响[J]. 江西中医药大学学报, 2017, 29(3): 90-93.
[18] 李惠, 金亚宏, 姜延良. 六味地黄汤对小鼠诱发性肺腺瘤P53基因表达的影响[J]. 中国实验方剂学杂志, 1997, 3(3): 17-19.
[19] 郭慧君, 朱金华, 刘春花, 等. 不同滋阴中药对小鼠诱发性肺肿瘤发生及抗肿瘤免疫能力的影响[J]. 中国实验方剂学杂志, 2012, 18(13): 226-229.
[20] 孙昊鑫, 余世平, 朱金华, 等. 二冬膏对乌拉坦诱导肺肿瘤模型鼠TNF-α､IL-10､TGF-β1及肿瘤发生的影响[J]. 中药药理与临床, 2015, 31(6): 7-10.
[21] 熊秋迎, 朱金华, 孙昊鑫, 等. 清燥救肺汤对乌拉坦诱导肺癌模型树TGF-β､Smad2和p38MARK的影响[J]. 中药药理与临床, 2018, 34(3): 14-17.
[22] 杜钢军, 林海红, 许启泰, 等. 阳和汤对乌拉坦诱导小鼠肺癌的动态影响[J]. 时珍国医国药, 2008, 19(5): 1151-1153.
[23] Zhang, Z., Wang, Y., Yao, R., et al. (2004) Cancer Chemopreventive Activity of Chinese Herbs (Antitumor B) in Mouse Lung Tumor Models. Oncogene, 23, 3841-3850. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, Y., Zhang, Z., Garbow, J.R., et al. (2009) Chemoprevention of Lung Squamous Cell Carcinoma in Mice by a Mixture of Chinese Herbs. Cancer Prevention Research, 2, 634-640. [Google Scholar] [CrossRef] 
[25] 杜振华, 姚静静, 李自波, 等. 当归赤小豆汤对乌拉坦诱导小鼠肺癌的预防作用[J]. 河南大学学报(医学版), 2017, 36(3): 153-155.
[26] Le, H.T., Nguyen, H.T., Min, H.-Y., et al. (2018) Panaxynol, a Natural Hsp90 Inhibitor, Effectively Targets both Lung Cancer Stem and Non-Stem Cells. Cancer Letters, 412, 297-307. [Google Scholar] [CrossRef] [PubMed]
[27] 孔桂菊, 杜鸿志, 袁胜涛, 等. 金花茶正丁醇提取物对乌拉坦诱导小鼠肺癌作用研究[J]. 亚太传统医药, 2015, 11(21): 4-7.
[28] Monteillier, A., Voisin, A., Furrer, P., et al. (2018) Intranasal Administration of Resveratrol Successfully Prevents Lung Cancer in A/J Mice. Scientific Reports, 8, Article No. 14257. [Google Scholar] [CrossRef] [PubMed]
[29] Pan, J., Zhang, Q., Liu, Q., et al. (2014) Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function. Cancer Prevention Research, 7, 1149-1159. [Google Scholar] [CrossRef] 
[30] Pan, J., Zhang, Q., Li, K., et al. (2014) Chemoprevention of Lung Squamous Cell Carcinoma by Ginseng. Cancer Prevention Research, 6, 530-540. [Google Scholar] [CrossRef] 
[31] Nakachi, K., Matsuyama, S., Miyake, S., et al. (2000) Preventive Effects of Drinking Green Tea on Cancer and Cardiovascular Disease: Epidemiological Evidence for Multiple Targeting Prevention. Biofactors, 13, 49-54. [Google Scholar] [CrossRef] [PubMed]
[32] Huang, J., Chen, S., Shi, Y., et al. (2017) Epigallocatechin Gallate from Green Tea Exhibits Potent Anticancer Effects in A549 Non-Small Lung Cancer Cells by Inducing Apoptosis, Cell Cycle Arrest and Inhibition of Cell Migaration. Journal of Buon, 22, 1422-1427.
[33] Jin, X., Che, D., Zhang, Z., et al. (2016) Ginseng Consumption and Risk of Cancer: A Meta-Analysis. Journal of Ginseng Research, 40, 269-277. [Google Scholar] [CrossRef] [PubMed]
[34] Xu, Q., Fang, X. and Chen, D. (2003) Pharmacokinetics and Bioavailability of Ginsenoside Rb1 and Rg1 from Panax Notoginseng in Rats. Journal of Ethnopharmacology, 84, 187-192. [Google Scholar] [CrossRef] 
[35] Duan, Z., Deng, J., Dong, Y., et al. (2017) Anticancer Effects of Ginsenoside Rk3 on Non-Small Cell Lung Cancer Cells: In Vitro and in Vivo. Royal Society of Chemistry, 8, 3723-3736.
[36] Ge, G., Yan, Y. and Cai, H. (2017) Ginsenoside Rh2 Inhibited Proliferation by Inducing ROS Mediated ER Stress Dependent Apoptosis in Lung Cancer Cell. Biological and Pharmaceutical Bulletin, 40, 2117-2124. [Google Scholar] [CrossRef] [PubMed]
[37] Leem, D., Shin, J., Kim, K., et al. (2018) Dammarane-Type Triterpene Ginsenside-Rg18 Inhibits Human Non-Small Cell Lung Cancer A549 Cell Proliferation via G1 Phase Arrest. Oncology Letters, 15, 6043-6049.
[38] Chen, C., Kao, C., Chiu, M., et al. (2017) The Anti-Cancer Effects and Mechanisms of Scutellaria barbata D.Don on CL1-5 Lung Cancer Cells. Oncotarget, 8, 109340-109357. [Google Scholar] [CrossRef] [PubMed]
[39] Wang, Q., Acharaya, N., Liu, Z., et al. (2018) Enhanced Anti-cancer Effects of Scutellaria barbata D.Don in Combination with Traditional Chinese Medicine Components on Non-Small Cell Lung Cancer Cells. Journal of Ethnopharmacology, 217, 140-151. [Google Scholar] [CrossRef] [PubMed]
[40] Tang, L., Liu, J., Zhu, L., et al. (2018) Curcumin Inhibits Growth of Human NCI-H292 Lung Squamous Cell Carcinoma Cells by Increasing Foxa2 Expression. Frontiers in Pharmacology, 9, 1-9. [Google Scholar] [CrossRef] [PubMed]
[41] Liu, F., Gao, S., Yang, Y., et al. (2018) Anitumor Activity of Curcumin by Modulation of Apoptosis and Autophagy in Human Lung Cancer A549 Cells Throung Inhibiting PI3K/AKt/mTOR Pathway. Oncology Reports, 39, 1523-1531.
[42] Wang, J.Y., Wang, X., Wang, X.J., et al. (2018) Curcumin Inhibits the Growth via Wnt/β-Catenin Pathway in Non-Small-Cell Lung Cancer Cells. European Review for Medical and Pharmacological Sciences, 22, 7492-7499.
[43] Fan, J., Wu, M., Wang, J., et al. (2018) 1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one Induces Lung Cancer Cell Apoptosis via the PI3K/Akt and ERK1/2 Pathways. Journal of Cellular Physiology, 1-14.
[44] Park, B., Lee, S.A., Moon, S.M., et al. (2018) Anthricin-Induced Caspase-Dependent Apoptosis through IGF1R/PI3K/AKT Pathway Inhibition in A549 Human Non-Small Lung Cancer Cells. Oncology Reports, 39, 2769-2776.
[45] Gu, J.J., Qiao, K.S., Sun, P., et al. (2018) Study of EGCG Induced Apoptosis in Lung Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway. European Review for Medical and Pharmacological Sciences, 22, 4557-4563.
[46] Feng, L., Au-yeung, W., Xu, Y., et al. (2017) Oleanolic Acid from Prunella vulgaris L. Induces SPC-A-1 Cell Line Appptosis via Regulation of Bax, Bad and Bcl-2 Expression. Asian Pacific Journal of Cancer Prevention, 12, 403-408.
[47] Xu, X. and Zhu, Y. (2017) Curcumin Inhibits Human Non-Small Cell Lung Cancer Xenografts by Targeting STAT3 Pathway. American Journal of Translational Research, 9, 3633-3641.
[48] 杨蕾, 张振海, 贾晓斌. 人参稀有皂苷组分联合紫杉醇治疗A549肺癌的实验研究[J]. 中国中药杂志, 2018, 43(7): 1146-1452.
[49] Yang, J., Yang, G., Hou, G., et al. (2015) Scutellaria barbata D.Don Polysaccharides Inhibit the Growth of Calu-3 Xenograft Tumors via Suppression of the Her2 Pathway and Angipgenesis. Oncology Letters, 9, 2721-2725. [Google Scholar] [CrossRef] [PubMed]
[50] He, L., Zhang, E., Shi, J., et al. (2013) (-)-Epigallocatechin-3-Gallate Inhibits Human Papillomavirus (HPV)-16 Oncoprotein-Induced Angiogenesis in Non-Small Cell Lung Cancer Cells Bu Targeting HIF-1α. Cancer Chemotherapy, 71, 713-725. [Google Scholar] [CrossRef] [PubMed]
[51] Liu, S., Xin, X., Hua, T., et al. (2016) Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis. PLoS ONE, 11, e0166658.
[52] Shiau, A., Shen, Y., Hsieh, J., et al. (2014) Scutellaria barbata Inhibits Angiofenesis through Downregulation of HIF-1α in Lung Tumor. Environmental Toxicology, 29, 363-370. [Google Scholar] [CrossRef] [PubMed]
[53] Li, X., Ma, S., Yang, P., et al. (2018) Anticancer Effects of Curcumin on Nude Mice Bearing Lung Cancer A549 Cell Subsets SP and NSP Cells. Oncology Letters, 16, 6756-6762. [Google Scholar] [CrossRef] [PubMed]
[54] 朱湘亮, 潘频华. 鸦胆子油乳对人非小细胞肺癌A549细胞增殖､迁移和自噬的影响及机制[J]. 中南大学学报(医学版), 2018, 43(11): 1202-1208.
[55] Yang, J., Wu, W., Wen, J., et al. (2017) Liposomal Honokiol Induced Lysosomal Degradation of Hsp90 Client Proteins and Protective Autophagy in Both Gefitinib-Sensitive and Gefitinib-Resistant NSCLC Cells. Biomaterials, 141, 188-198. [Google Scholar] [CrossRef] [PubMed]
[56] Zhou, J., Su, C., Luo, H., et al. (2018) Curcumin Converts Foxp3+ Regulatory T Cells to T Helper 1 Cells in Patients with Lung Cancer. Journal of Cellular Biochemistry, 119, 1420-1428. [Google Scholar] [CrossRef] [PubMed]
[57] Feng, L., Jia, X., Shi, F., et al. (2010) Identification of Two Polysaccharides from Prunella vulgaris L. and Evaluation on Their Anti-Lung Adenocarcinoma Activity. Molecules, 15, 5093-5103. [Google Scholar] [CrossRef] [PubMed]
[58] Joo, E.J., Chun, J., Han, Y.W., et al. (2015) Novel Roles of Ginsenoside Rg3 in Apoptosis through Downregulation of Epidermal Growth Factor Receptor. Chemico-Biological Interactions, 233, 25-34. [Google Scholar] [CrossRef] [PubMed]
[59] Song, J.M., Anandharaj, A., Upadhyaya, P., et al. (2016) Honokiol Suppresses Lung Tumorigenesis by Targeting EGFR and Its Downstream Effectors. Oncotarget, 7, 57753-57769. [Google Scholar] [CrossRef] [PubMed]
[60] Jiang, A.-P., Zhou, D.-H., Meng, X.-L., et al. (2014) Down-Regulation of Epidermal Growth Factor Receptor by Curcumin-Induced UBE1L in Human Bronchial Epithelial Cells. Journal of Nutritional Biochemistry, 25, 241-249. [Google Scholar] [CrossRef] [PubMed]
[61] Luo, L., Li, Y., Liu, Z., et al. (2017) Honokiol Induces Apoptosis, G1 Arrest, and Autopjagy in KRAS Mutant Lung Cancer Cells. Frontiers in Pharmacologh, 8, 1-11. [Google Scholar] [CrossRef] [PubMed]
[62] Lee, H.J., Goo, J.M., Lee, C.H., et al. (2009) Predictive CT Findings of Malignancy in Ground-Glass Nodules on Thin-Section Chest CT: The Effects on Radiologist Performance. European Radiology, 19, 552-560. [Google Scholar] [CrossRef] [PubMed]
[63] Migliore, M., Fornito, M., Palazzolo, M., et al. (2018) Ground Glass Opacities Management in the Lung Cancer Screening Era. Annals of Translational Medicine, 6, 90-97. [Google Scholar] [CrossRef] [PubMed]